Document Detail


Importance of levosimendan on right ventricular function in patients with biventricular heart failure.
MedLine Citation:
PMID:  20404640     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
Alim Erdem; Mehmet Birhan Yilmaz
Publication Detail:
Type:  Comment; Letter    
Journal Detail:
Title:  Critical care medicine     Volume:  38     ISSN:  1530-0293     ISO Abbreviation:  Crit. Care Med.     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-04-20     Completed Date:  2010-05-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0355501     Medline TA:  Crit Care Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1389-90; author reply 1390-1     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Hemodynamics / drug effects
Humans
Hydrazones / pharmacology*,  therapeutic use
Pyridazines / pharmacology*,  therapeutic use
Shock, Cardiogenic / drug therapy*,  physiopathology
Vasodilator Agents / pharmacology*,  therapeutic use
Ventricular Function, Right / drug effects*
Chemical
Reg. No./Substance:
0/Hydrazones; 0/Pyridazines; 0/Vasodilator Agents; 131741-08-7/simendan
Comments/Corrections
Comment On:
Crit Care Med. 2009 Dec;37(12):3017-23   [PMID:  19661807 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Health care providers' attitudes regarding family presence during resuscitation of adults: an integr...
Next Document:  Management of intramedullary cystic pilocytic astrocytoma with rhenium-186 intracavitary irradiation...